NCT05044949View on ClinicalTrials.gov

Study Evaluating the Safety and Tolerability of a Probioitc

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

January 20, 2022

Conditions
Healthy VolunteersTolerabilitySafety
Interventions
OTHER

Probiotic

The study product is a probiotic strain

OTHER

Placebo

The study product is a placebo to the probiotic strain

Trial Locations (2)

75237

CTC, Dag Hammarskjölds väg 10B, Uppsala

752 37

Clinical Trial Consultants AB, Uppsala

Sponsors

Lead Sponsor

BioGaia AB
All Listed Sponsors
lead

BioGaia AB

INDUSTRY

NCT05044949 - Study Evaluating the Safety and Tolerability of a Probioitc | Biotech Hunter | Biotech Hunter